A DLBCL mouse xenotransplantation model demonstrated that the inhibition of the paracrine VEGFR-2 pathway reduced growth of an established lymphoma and correlated with decreased tumor angiogenesis (226). The gene discussed is KDR; the disease is neoplasm.